Targeting intestinal epithelial barrier function to prevent onset of arthritis

Gut microbial dysbiosis has been associated with the development of autoimmune disease. However, the mechanisms, by which microbial dysbiosis impacts the transition from asymptomatic autoimmunity to inflammatory disease, remain incompletely characterized. Herein, we identify intestinal barrier integrity as a key checkpoint translating autoimmunity to inflammation.